Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 107, Issue 5, 2009, Pages 678-684

  Lee, Jae Il ^a   Jin, Bo Hyong ^a   Kim, Mi Ae ^a   Yoon, Hye Jung ^a   Hong, Sam Pyo ^a   Hong, Seong Doo ^a  

^a School of Dentistry   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCR4 PROTEIN, HUMAN; GELATINASE A; GELATINASE B; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CANCER STAGING; ENZYME IMMUNOASSAY; FEMALE; GENETICS; HUMAN; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KAPLAN-MEIERS ESTIMATE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 67349095611     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2008.12.047     Document Type: Article

References (32)

1. Sankaranarayanan R., Masuyer E., and Swaminathan R. Head and neck cancer: a global perspective on epidemiology and survival. Anticancer Res 18 (1998) 4779-4786
2. Carvalho A.L., Ikeda M.K., Magrin J., and Kowalski L.P. Trends of oral and oropharyngeal cancer survival over five decades in 3267 patients treated in a single institution. Oral Oncol 40 (2004) 71-76
3. Carvalho A.L., Magrin J., and Kowalski L.P. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Dis 9 (2003) 112-118
4. Shah J.P., and Lydiatt W. Treatment of cancer of the head and neck. Cancer J Clin 45 (1995) 352-368
5. Arya M., Patel H.R., and Williamson M. Chemokines: key players in cancer. Curr Med Res Opin 19 (2003) 557-564
6. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 410 (2001) 50-56
7. Scotton C.J., Wilson J.L., Milliken D., Stamp G., and Balkwill F.R. Epithelial cancer cell migration: a role for chemokine receptors?. Cancer Res 61 (2001) 4961-4965
8. Taichman R.S., Cooper C., Keller E.T., Pienta K.J., Taichman N.S., and McCauley L.K. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 62 (2002) 1832-1837
9. Schrader A.J., Lechner O., Templin M., Dittmar K.E., Machtens S., Mengel M., et al. CXCR4/CXCL12 expression and signalling in kidney cancer. Br J Cancer 86 (2002) 1250-1256
10. Zhou Y., Larsen P.H., Hao C., and Yong V.W. CXCR4 is a major chemokine receptor on glioma cells and mediates their survival. J Biol Chem 277 (2002) 49481-49487
11. Kijima T., Maulik G., Ma P.C., Tibaldi E.V., Turner R.E., Rollins B., et al. Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. Cancer Res 62 (2002) 6304-6311
12. Hwang J.H., Hwang J.H., Chung H.K., Kim D.W., Hwang E.S., Suh J.M., et al. CXC chemokine receptor 4 expression and function in human anaplastic thyroid cancer cells. J Clin Endocrinol Metab 88 (2003) 408-416
13. Ishikawa T., Nakashiro K., Hara S., Klosek S.K., Li C., Shintani S., et al. CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma. Int J Oncol 28 (2006) 61-66
14. Almofti A., Uchida D., Begum N.M., Tomizuka Y., Iga H., Yoshida H., et al. The clinicopathological significance of the expression of CXCR4 protein in oral squamous cell carcinoma. Int J Oncol 25 (2004) 65-71
15. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hansen B., DeCarlo A., et al. Matrix metalloproteinases. A review. Crit Rev Oral Biol Med 4 (1993) 197-250
16. Gao Z.B., Duan Y.Q., Zhang L., Chen D.W., and Ding P.T. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma. Int J Mol Med 16 (2005) 599-603
17. Hong S.D., Hong S.P., Lee J.I., and Lim C.Y. Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36 (2000) 207-213
18. Samara GJ, Lawrence DM, Chiarelli CJ, Valentino MD, Lyubsky S, Zucker S, et al. CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. Cancer Lett 200;214:231-41.
19. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., et al. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp Cell Res 310 (2005) 117-130
20. Chinni S.R., Sivalogan S., Dong Z., Filho J.C., Deng X., Bonfil R.D., et al. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Prostate 66 (2006) 32-48
21. Singh S., Singh U.P., Grizzle W.E., and Lillard Jr. J.W. CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84 (2004) 1666-1676
22. Schluter C., Duchrow M., Wohlenberg C., Becker M.H., Key G., Flad H.D., et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 123 (1993) 513-522
23. Hall J.M., and Korach K.S. Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17 (2003) 792-803
24. Lapteva N., Yang A.G., Sanders D.E., Strube R.W., and Chen S.Y. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo. Cancer Gene Ther 12 (2005) 84-89
25. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M., Haller D.G., and Morrow M. AJCC cancer staging manual. 6th ed. (2002), Springer, Chicago
26. Neville B.W., Damm D.D., Allen C.M., and Bouquot J.E. Oral and maxillofacial pathology. 2nd ed. (2002), Saunders, Philadelphia
27. Kato M., Kitayama J., Kazama S., and Nagawa H. Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5 (2003) R144-R150
28. Katayama A., Ogino T., Bandoh N., Nonaka S., and Harabuchi Y. Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma. Clin Cancer Res 11 (2005) 2937-2946
29. Juuti A., Lundin J., Nordling S., Louhimo J., and Haglund C. Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer. Oncology 71 (2006) 61-68
30. Muller A., Sonkoly E., Eulert C., Gerber P.A., Kubitza R., Schirlau K., et al. Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer 118 (2006) 2147-2157
31. Delilbasi C.B., Okura M., Iida S., and Kogo M. Investigation of CXCR4 in squamous cell carcinoma of the tongue. Oral Oncol 40 (2004) 154-157
32. Hong J.S., Pai H.K., Hong K.O., Kim M.A., Kim J.H., Lee J.I., et al. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells. J Oral Pathol Med 38 (2009) 214-219